Disease Information & Support


The Word:


Generic name Rituximab
Pronunciation rih-TUK-si-mab
Brand name(s), other common name(s) Rituxan®
Drug type  Monoclonal antibody
How the drug is given Intravenously (IV)

Rituximab is a monoclonal antibody. It is FDA approved alone or with other medications to treat people who have certain types of non-Hodgkin lymphoma.

Side effects needing medical attention: Fever; chills; difficulty breathing or shortness of breath; sensation of tongue or throat swelling; hives; itching; weakness; headache; nausea; vomiting; flushing; palpitations; chest pain; rash; dizziness; coughing; unusual tiredness or fatigue; unusual bruising or bleeding; muscle or joint pain; abdominal pain; diarrhea.

In patients with prior hepatitis B (HBV) infection, HBV reactivation may occur when the body's immune system is impaired.

Side effects needing medical attention after stopping this medication: Black, tarry stools; blood in urine or stools; painful or difficult urination; pinhead-sized red spots on skin; unusual bleeding or bruising; unusual tiredness or weakness.


For information on how to manage the costs of drug therapy, please see Financial Matters and Prescription Drug Coverage, or to speak with an Information Specialist, call (800) 955-4572.

last updated on Thursday, October 03, 2013